Prelude Capital Management’s Axsome Therapeutics AXSM Stock Holding History

Prelude Capital Management’s Portfolio AXSM Stock Details AXSM Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$389K	Buy
2022 Q1	–	Hold
2021 Q4	–	Hold
2021 Q3	–	Hold
2020 Q2	–	Hold
2020 Q1	–	Hold
2019 Q4	–	Hold